JP2015500387A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500387A5
JP2015500387A5 JP2014547145A JP2014547145A JP2015500387A5 JP 2015500387 A5 JP2015500387 A5 JP 2015500387A5 JP 2014547145 A JP2014547145 A JP 2014547145A JP 2014547145 A JP2014547145 A JP 2014547145A JP 2015500387 A5 JP2015500387 A5 JP 2015500387A5
Authority
JP
Japan
Prior art keywords
chemically modified
kda
molecular weight
modified heparin
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014547145A
Other languages
English (en)
Japanese (ja)
Other versions
JP6703806B2 (ja
JP2015500387A (ja
Filing date
Publication date
Priority claimed from PCT/SE2011/051538 external-priority patent/WO2013095215A1/en
Application filed filed Critical
Publication of JP2015500387A publication Critical patent/JP2015500387A/ja
Publication of JP2015500387A5 publication Critical patent/JP2015500387A5/ja
Application granted granted Critical
Publication of JP6703806B2 publication Critical patent/JP6703806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2014547145A 2011-12-19 2012-12-19 低抗凝固剤ヘパリン Active JP6703806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SEPCT/SE2011/051538 2011-12-19
PCT/SE2011/051538 WO2013095215A1 (en) 2011-12-19 2011-12-19 Low anticoagulant heparins
PCT/SE2012/051428 WO2013095276A1 (en) 2011-12-19 2012-12-19 Low anticoagulant heparins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018112162A Division JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Publications (3)

Publication Number Publication Date
JP2015500387A JP2015500387A (ja) 2015-01-05
JP2015500387A5 true JP2015500387A5 (enExample) 2016-12-01
JP6703806B2 JP6703806B2 (ja) 2020-06-03

Family

ID=48668926

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014547145A Active JP6703806B2 (ja) 2011-12-19 2012-12-19 低抗凝固剤ヘパリン
JP2018112162A Pending JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018112162A Pending JP2018154848A (ja) 2011-12-19 2018-06-12 低抗凝固剤ヘパリン

Country Status (26)

Country Link
US (2) US9480702B2 (enExample)
EP (2) EP2794666B1 (enExample)
JP (2) JP6703806B2 (enExample)
CN (1) CN104053675B (enExample)
AU (1) AU2012354226B2 (enExample)
BR (1) BR112014014673B1 (enExample)
CA (2) CA2856918C (enExample)
CY (2) CY1120194T1 (enExample)
DK (2) DK2794666T3 (enExample)
ES (2) ES2668273T3 (enExample)
HR (2) HRP20180726T1 (enExample)
HU (2) HUE037555T2 (enExample)
IL (1) IL232903A (enExample)
IN (1) IN2014MN01056A (enExample)
MX (1) MX358439B (enExample)
MY (1) MY170069A (enExample)
NO (2) NO2794667T3 (enExample)
PH (1) PH12014501387A1 (enExample)
PL (2) PL2794667T3 (enExample)
PT (2) PT2794666T (enExample)
RS (2) RS57213B1 (enExample)
SI (2) SI2794666T1 (enExample)
SM (2) SMT201800218T1 (enExample)
TN (2) TN2014000237A1 (enExample)
WO (3) WO2013095215A1 (enExample)
ZA (1) ZA201403654B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20180124T1 (hr) 2011-12-19 2018-02-23 Dilafor Ab Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
GB2515315A (en) 2013-06-19 2014-12-24 Dilafor Ab New Processes
EP2965764A1 (en) * 2014-07-11 2016-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for treating vaso-occlusive crisis
ES2749076T3 (es) * 2014-04-30 2020-03-19 Inst Nat Sante Rech Med DNasa para uso en el tratamiento de crisis vaso-oclusivas
CN105504097B (zh) * 2015-12-30 2018-07-03 深圳市海普瑞药业集团股份有限公司 一种硫酸化肝素寡糖及其制备方法和应用
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
EP3773770B1 (en) * 2018-04-13 2023-11-29 University of Virginia Patent Foundation Compositions and methods for preparing and using non-immunogenic fast annealing microporous annealed particle hydrogels
CN109481692A (zh) * 2018-11-30 2019-03-19 东南大学 一种青蒿琥酯肝素衍生物及其药物组合物和应用
US12370138B2 (en) * 2022-03-29 2025-07-29 The Penn State Research Foundation Bioactive granular hydrogel scaffolds and use thereof
US12444880B2 (en) 2022-05-05 2025-10-14 Tego Innovations, Inc. Magnetic power distribution assembly
JP2025519467A (ja) * 2022-06-06 2025-06-26 アイエイチピー セラピューティクス インコーポレイテッド 化学的に修飾されたヘパリン
CN115448994B (zh) * 2022-09-28 2023-08-01 山东大学 一种可中和抗凝低分子量肝素及其制备方法和应用
CN120112299A (zh) 2022-09-29 2025-06-06 爱多拉动物健康公司 用于治疗疼痛和其他医学病症的硫酸化糖胺聚糖及其衍生片段的储存稳定的制剂
GB2625581A (en) * 2022-12-21 2024-06-26 Modus Therapeutics Ab New medical use
GB2627263A (en) * 2023-02-17 2024-08-21 Modus Therapeutics Ab New medical use
EP4665360A1 (en) 2023-02-17 2025-12-24 Modus Therapeutics AB New medical use of sevuparin in the treatment of endotoxemia
CN116854838A (zh) * 2023-06-30 2023-10-10 重庆望业药物研究有限公司 低分子多糖及其制备方法与应用
GB202407366D0 (en) * 2024-05-23 2024-07-10 Glycos Biomedical Ltd Preparation of medium molecular weight heparin

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
FR2614026B1 (fr) 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
ES2054975T3 (es) * 1988-10-07 1994-08-16 Hoechst Ag Composiciones antimalaricas que emplean quinidina, artemisinina y sus derivados.
SE9002550D0 (sv) 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
AU5442594A (en) 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) * 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
GB2299998B (en) * 1995-03-31 1997-03-26 Hamilton Civic Hospitals Res Compositions for inhibiting thrombogenesis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
EP0867452A4 (en) 1996-10-15 2000-07-26 Toray Industries MATURATION AGENT FOR CERVICAL CHANNELS
GB9711443D0 (en) 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
AU1173599A (en) * 1997-11-20 1999-06-15 Ikuo Yamashina Low-molecular heparin modification and remedy for skin ulcer
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
EP1059304B1 (en) 1998-02-26 2006-04-26 Seikagaku Corporation Novel polysaccharide derivatives, process for the production thereof and medicinal compositions containing the same as the active ingredient
US6028061A (en) * 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
KR20010030803A (ko) * 1998-07-31 2001-04-16 야마야 와따루 신규 글리코사미노글리칸 및 이를 함유하는 의약 조성물
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
CA2422059C (en) * 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
SE521676C2 (sv) 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2003088980A1 (en) 2002-04-18 2003-10-30 Embury Stephen H Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP2258349B1 (en) * 2004-05-11 2014-07-16 Egalet Ltd. Swellable dosage form comprising gellan gum
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) * 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
WO2007014049A2 (en) * 2005-07-22 2007-02-01 The Regents Of The University Of California Heparin compositions and selectin inhibition
CA2616230A1 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
WO2007140231A2 (en) * 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
WO2009059284A2 (en) * 2007-11-02 2009-05-07 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8569262B2 (en) * 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8445436B2 (en) 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
EP2281008B1 (en) * 2008-04-04 2017-01-04 University of Utah Research Foundation Alkylated and sulfated hyaluronan compounds, methods for their preparation and use thereof
CA2767560A1 (en) * 2008-07-25 2010-01-28 Alphapharm Pty Ltd Atovaquone with a particle size diameter range (d90) of greater than 3um to about 10um
ES2458818T3 (es) 2009-04-16 2014-05-07 Momenta Pharmaceuticals, Inc. Métodos para evaluar la actividad de una composición de polisacárido
US20120108538A1 (en) * 2009-06-30 2012-05-03 James Beeson Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
HRP20180124T1 (hr) 2011-12-19 2018-02-23 Dilafor Ab Glikozaminoglikani koji nisu antikoagulanti koji sadrže ponavljajuću jedinicu disaharida i njihova medicinska upotreba
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
MY175743A (en) 2012-03-26 2020-07-07 Dilafor Ab Combination treatment comprising sulphated glycosaminoglycans for inducing labor
HK1203370A1 (en) 2012-03-26 2015-10-30 迪乐方有限责任公司 Method for treatment of labor arrest

Similar Documents

Publication Publication Date Title
JP2015500387A5 (enExample)
SI2794667T1 (en) Low anticoagulant heparins
JP2015500388A5 (enExample)
Cassinelli et al. Old and new applications of non-anticoagulant heparin
CA2397964A1 (en) Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
JP2009538386A5 (enExample)
JP2005506326A5 (enExample)
RU2010122324A (ru) Полисахаридные композиции, не обладающие антикоагулянтными свойствами
RU2014129816A (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
JP2003523460A5 (enExample)
CN1547477A (zh) 具有抗血管生成活性且没有抗凝作用的作为类肝素酶抑制剂的部分脱硫酸化糖胺聚糖衍生物
RU2014143008A (ru) Способ лечения остановки родов
EA033936B1 (ru) Усовершенствованный способ получения сульфатированной ha высокой степени чистоты
JP4865552B2 (ja) ヘパリン−誘導オリゴ糖混合物、その製造およびその混合物を含有する医薬組成物
JPH10218902A5 (enExample)
US20110178039A1 (en) Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
JP4897991B2 (ja) 超低分子量ヘパリン組成物
JP2015516415A5 (enExample)
KR20200031059A (ko) 황산화 히알루론산 기반의 하이드로겔 및 이를 포함하는 약제학적 조성물
NZ537411A (en) Heparin-derived polysaccharide mixtures and preparation method
HK1200471B (en) Low anticoagulant heparins
HK1059273B (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same
HK1059273A1 (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same